First Treatment Options for Ovarian Cancer
- There is no single path for ovarian cancer treatment
- Some people may begin with chemotherapy before surgery (neoadjuvant chemotherapy) to shrink the tumor
- Others may start with primary debulking surgery to manually remove as much of the tumor as possible
- Age, health, and lifestyle influence which treatment to begin with
- Discuss with your doctor the treatment option that's best for you
Which Comes First: Neoadjuvant Chemotherapy or Debulking Surgery?
The most common type of surgery for ovarian cancer is called debulking surgery, and the intention of this procedure is to remove as much of the tumor as possible. When chemotherapy is administered as an initial treatment before surgery, it’s called neoadjuvant chemotherapy. Most chemotherapy for ovarian cancer involves a combination of two drugs–usually taxol and carboplatin. Patients usually receive six treatments; all six may be given after surgery, or three might precede surgery, with three following it.
Read More"Chemotherapy versus primary debulking surgery is something that you would discuss with your doctor," says Dr. Gilian Hsieh, gynecologic oncologist at the Sutter Bay Medical Foundation in the Bay Area in California. "It depends on your goals in terms of how much surgical morbidity [potential problems] you're willing to tolerate."
Studies showing that the success of treatment is the same regardless of whether surgery or chemotherapy is done first are especially good news considering that when the COVID-19 pandemic broke out some doctors were postponing surgery to protect patients from the risk of exposure to the virus in the hospital. Some patients who might have qualified for surgery first opted to begin treatment with chemotherapy instead.
There Is No One-Size-Fits-All Treatment
In addition to age and overall health, another factor that goes into the decision of which treatment to begin with has to do with lifestyle. Debulking surgery involves time in the hospital and recovery time afterwards, whereas while chemotherapy certainly has side effects, most of these can be managed well enough that women can continue with many normal activities.
Dr. Hsieh remembers one patient in her seventies who was very healthy and a good candidate for primary debulking surgery. But the woman opted for neoadjuvant chemotherapy instead. She was a caregiver for her grandchildren, and wanted to be able to continue taking care for them during her treatment. "She felt that neoadjuvant chemotherapy would be more in line with her goals for quality of life and maintaining good function during her treatment," says Dr. Hsieh.
After three cycles of chemotherapy, the woman was able to undergo a less extensive surgical procedure. "For her, I felt comfortable doing a laparoscopic [minimally invasive] debulking surgery," says Dr. Hsieh. After the initial chemotherapy and the surgery there were no remaining tumor cells that could be detected. She finished her initial therapy with three more rounds of chemotherapy. "She's been off treatment for two years now and is doing really well," says Dr. Hsieh.
Treatment for ovarian cancer doesn’t take the same path for everyone. Depending on the aggressiveness of the cancer and your health and lifestyle, different procedures might make sense at different times, allowing treatment to be individualized to you. Your doctor can work closely with you to ensure that you find the best approach to treating your cancer, while meeting your lifestyle goals.
Learn more about SurvivorNet's rigorous medical review process.